News
The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...
Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels ...
Drugs that promise rapid and effortless weight loss once seemed like the stuff of fairytales. Now, even if we’re not “on the ...
Dizziness, sudden hunger, or easy anger? Could be a sign of low blood sugar. Recognize these 5 symptoms before it's too late!
7h
HealthShots on MSNMounjaro side effects: 10 common and long-term reactions you shouldn’t ignoreMounjaro, one of the brand names for tirzepatide, is a drug that is beneficial for people with type 2 diabetes. This ...
Dr. Reddy's faces revenue slowdown post gRevlimid boost, but new investments and partnerships offer long-term growth ...
With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March ...
Women using weight-loss injections are being cautioned to ensure they use reliable contraception, following reports that ...
20h
Best Life on MSNOzempic Users Face 2x Higher Risk of Permanent Vision Loss, Researchers WarnPatients who use GLP1 drugs to help control their type 2 diabetes are at an upward risk of developing age-related macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results